The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Dec. 08, 2017
Applicant:
Crystal Pharmaceutical (Suzhou) Co., Ltd., Suzhou, Jiangsu, CN;
Inventors:
Minhua Chen, Suzhou, CN;
Yanfeng Zhang, Suzhou, CN;
Xiaoting Zhai, Suzhou, CN;
Kaiqiang Yan, Suzhou, CN;
Xiaoyu Zhang, Suzhou, CN;
Assignee:
CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD., Suzhou, Jiangsu, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/91 (2006.01); C07D 413/06 (2006.01); C07D 471/04 (2006.01); A61K 31/517 (2006.01);
U.S. Cl.
CPC ...
C07D 239/91 (2013.01); A61K 31/517 (2013.01); C07D 413/06 (2013.01); C07D 471/04 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present disclosure relates to novel crystalline forms of a bromodomain protein inhibitor 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxyquinazolin-4(3H)-one and processes for preparation and use thereof, relating to pharmaceutical industry. Form CS2, Form CS8, Form CS13, Form CS20, Form CS1, Form CS7, Form CS9, Form CS11 and Form CS4 of the present disclosure can be used for preparing drugs treating cardiovascular, cholesterol or lipid-related disorders.